RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of GTHP
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in Guided Therapeutics, Inc. stock price on Tuesday moving 32.21% between high and low
(Updated on Jul 02, 2024)

Sell candidate since Jul 01, 2024 Loss -9.00% PDF

The Guided Therapeutics, Inc. stock price fell by -9.00% on the last day (Tuesday, 2nd Jul 2024) from $0.100 to $0.0910. During the last trading day the stock fluctuated 32.21% from a day low at $0.0832 to a day high of $0.110. The price has fallen in 4 of the last 10 days and is down by -39.33% for this period. Volume has increased on the last day by 69 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 84 thousand shares were bought and sold for approximately $7.68 thousand.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 9.79% during the next 3 months and, with a 90% probability hold a price between $0.0779 and $0.177 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

GTHP Signals & Forecast

There are few to no technical positive signals at the moment. The Guided Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $0.108 and $0.106. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, June 14, 2024, and so far it has fallen -42.77%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Guided Therapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Guided Therapeutics, Inc. stock

Guided Therapeutics, Inc. finds support from accumulated volume at $0.0900 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0268 between high and low, or 32.21%. For the last week, the stock has had daily average volatility of 11.68%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GTHP) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect Guided Therapeutics, Inc. to open at $0.0947, and during the day (based on 14 day Average True Range), to move between $0.0720 and $0.110, which gives a possible trading interval of +/-$0.0190 (+/-20.91%) up or down from last closing price. If Guided Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 41.81% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0900 (1.10%) than the resistance at $0.0980 (7.69%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Guided Therapeutics, Inc. stock A Buy?

The Guided Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Guided Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.136 Strong Sell Candidate Downgraded

Predicted Opening Price for Guided Therapeutics, Inc. of Wednesday, July 3, 2024

Fair opening price July 3, 2024 Current price
$0.0947 ( 4.10%) $0.0910

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for GTHP

Fibonacci Support & Resistance Levels

Level Price
R3 0.122 33.55%
R2 0.111 22.30%
R1 0.105 15.35%
Price 0.0910
S1 0.0845 -7.15%
S2 0.0782 -14.10%
S3 0.0679 -25.35%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.109 19.78%
R2 0.100 9.89%
R1 0.0980 7.69%
Price 0.0910
S1 0.0900 -1.10%
S2 0.0850 -6.59%
S3 0.0805 -11.54%

FAQ

What is the symbol for Guided Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Guided Therapeutics, Inc. is GTHP and it is traded on the PINK (Pink Sheets).

Should I buy or sell Guided Therapeutics, Inc. Stock?
The Guided Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Guided Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy Guided Therapeutics, Inc. Stock?
Guided Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Guided Therapeutics, Inc. Stock.

What's the current price of Guided Therapeutics, Inc. Stock?
As of the end of day on the Jul 02, 2024, the price of an Guided Therapeutics, Inc. (GTHP) share was $0.0910.

What is the 52-week high and low for Guided Therapeutics, Inc. Stock?
The 52-week high for Guided Therapeutics, Inc. Stock is $0.300 and the 52-week low is $0.0640.

What is the market capitalization of Guided Therapeutics, Inc. Stock?
As of the Jul 02, 2024, the market capitalization of Guided Therapeutics, Inc. is 5.569M.

When is the next earnings date for Guided Therapeutics, Inc.?
The upcoming earnings date for Guided Therapeutics, Inc. is Aug 08, 2024.
Click to get the best stock tips daily for free!

About Guided Therapeutics, Inc.

Guided Therapeutics. Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its n... GTHP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT